Vimarsana
Biggest News Aggregation in the World

Page 22 - Cochlear Limited News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cochlear Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cochlear Limited Today - Breaking & Trending Today

Sensorion receives Orphan Drug Designation for OTOF-GT for the treatment of otoferlin gene-mediated hearing loss from the US Food and Drug Administration - Vimarsana News

Sensorion receives Orphan Drug Designation for OTOF-GT for the treatment of otoferlin gene-mediated hearing loss from the US Food and Drug Administration

Designation follows recent FDA award of Rare Pediatric Disease Designation to Sensorion for OTOF-GT program Sensorion is on track to file a CTA for OTOF-GT in H1 2023 Regulatory News:

Sensorion Will Attend In-Person the Jefferies London Healthcare Conference - Vimarsana News

Sensorion Will Attend In-Person the Jefferies London Healthcare Conference

Regulatory News: Sensorion (FR0012596468 ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent

Hearing Aids Market Foreseen to Grow Exponentially by 2028 - Vimarsana News

Hearing Aids Market Foreseen to Grow Exponentially by 2028

Technological advancements and rising incidences of hearing problems are the most impacting factors responsible for the overall hearing aids market growth.

New Medicare Fee Schedule; Feds Investigate Alleged Abortion Denial; Oz's AATS Ban - Vimarsana News

New Medicare Fee Schedule; Feds Investigate Alleged Abortion Denial; Oz's AATS Ban

Health news and commentary from around the Web gathered by <em>MedPage Today</em> staff

FDA approves Cochlear's Nucleus 8 Sound Processor, smaller, smarter, better connected cochlear implant technology - Vimarsana News

FDA approves Cochlear's Nucleus 8 Sound Processor, smaller, smarter, better connected cochlear implant technology

/PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, receives U.S. Food and Drug Administration (FDA) approval for...